IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: study rationale and designXuehong Chu, Chuanjie Wu, Chaoqun Li et al.|Stroke and Vascular Neurology|2024Cited by 16
Effect of IL-6 receptor inhibition on infarct volume after endovascular treatment for ischaemic stroke: a phase 2, randomised, placebo-controlled trialXuehong Chu, Jing Lan, Zhengfei Ma et al.|EBioMedicine|2026Cited by 7
Albumin for patients with acute large-vessel occlusive stroke undergoing endovascular therapy (ARISE): the protocol of a randomized double-blind trialYuanyuan Liu, Xunming Ji, Xiao Song Dong et al.|Frontiers in Neurology|2025Cited by 1